ArticleTargets (Basel)2024

Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer's Disease.

Catherine Sharo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.